Promoting Racial Justice in Cancer Clinical Trials: Community Engaged Solutions for Bridging Gaps
Cancer Medicine · 2025-02 · 14 (4)
DOI: 10.1002/cam4.70690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 19.02.2025. Verfasst von Deana M Williams und 11 weiteren Autor:innen. Beteiligte Einrichtung: MultiCare Health System Institute for Research & Innovation, Puyallup, Washington, USA. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Neoplasms, Social Justice, Healthcare Disparities. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Andy Hill CARE Fund.
Abstract (Originalsprache)
Introduction
Racially and ethnically diverse populations are disproportionately burdened with and more likely to die from cancer than White populations but remain persistently underrepresented in cancer clinical trials. Thus, the safety and efficacy assessments of novel therapies may not apply to all populations, and guidelines are developed using trials that inadequately reflect our population. This study aims to explore healthcare experiences, cancer clinical trial perceptions, and solutions for bridging gaps in cancer clinical trials among communities of color.
Methods
We held a series of five focus groups with 23 survivors and caregivers of color. These sessions explored perspectives around cancer care and research, clinical trials recruitment and messaging, and priorities around addressing the current insufficiency in representation in cancer research.
Results
Our focus group data was analyzed using an inductive thematic approach. Four themes were present including (1) high motivation to participate in cancer trials and desire for better outreach and education within communities of color; (2) examples of just care as a model for improving access to clinical trials; (3) manifestations of power and inequity in healthcare inhibiting opportunities for clinical trial participation; and (4) the need for trust‐building at the healthcare, community, and interpersonal levels.
Conclusion
Our findings demonstrate that people of color strongly desire clinical trial options and discussions during cancer care, and trust‐building is foundational to opening pathways to research participation. We offer concrete steps for increasing racial justice in cancer clinical trials that serve as a point of reflection and guidance for healthcare professionals, researchers, and clinical trials teams.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MultiCare Health System Institute for Research & Innovation, Puyallup, Washington, USA.
- Clinical Trials Advisory Group, Puyallup, Washington, USA.
- MultiCare Cancer Institute, Tacoma, Washington, USA.
ORCID-Profile: Deana M Williams
Förderung
- Andy Hill CARE Fund
Zitieren
APA
Williams, D. M., Pflugeisen, C. M., Ameen, K., Chen, T. K., Cooks, S., Ray, B. C., Foster, M., Phillips, Sanchez, L., Hardiman, K., Smith, C., & Slim, J. (2025). Promoting Racial Justice in Cancer Clinical Trials: Community Engaged Solutions for Bridging Gaps. Cancer Medicine, 14(4). https://doi.org/10.1002/cam4.70690
Vancouver
Williams DM, Pflugeisen CM, Ameen K, Chen TK, Cooks S, Ray BC, et al. Promoting Racial Justice in Cancer Clinical Trials: Community Engaged Solutions for Bridging Gaps. Cancer Medicine. 2025;14(4). doi:10.1002/cam4.70690
BibTeX
@article{Williams2025,
author = {Williams, Deana M and Pflugeisen, Chaya M and Ameen, Khadijah and Chen, Toby K and Cooks, Sheree and Ray, Bernadette C and Foster, Melissa and Phillips, De and Sanchez, Lizbeth and Hardiman, Keywanna and Smith, Cynthia and Slim, Jennifer},
title = {Promoting Racial Justice in Cancer Clinical Trials: Community Engaged Solutions for Bridging Gaps},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {4},
doi = {10.1002/cam4.70690}
}
EUVIMED